Merck & Co. Inc.

NYS : MRK
Pharmaceuticals
Keniworth NJ
Revenue (US$ Millions)$42,237
Revenue Growth (%)-4.08%
Net Income (Millions)$11,920
Common Shares Outstanding (Millions)$2,838
Earnings per Share$4.07
Price To Earnings Ratio15.02
Total Equity (Millions)$48,647
Profit Margin 128.22%
Return on Equity23.95%
Long Term Debt (US$ Millions)$18,699
Debt To Equity Ratio (%)0.38%
Market Capitalization (US$ Millions)$161,178
Total Assets (US$ Millions)$98,335
Return on Assets (%)11.28
Current Assets (US$ Millions)$33,173
Inventories (US$ Millions)$5,571
Current Liabilities (US$ Millions)$18,766
Cost of Goods Sold (US$ Millions)$16,768
Asset Turnover0.43
Inventory Turnover2.84